Skip to main content

Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept

Reviews in Endocrine and Metabolic Disorders volume 18, pages 335–346 (2017)Cite this article

Abstract

In the last few years, more attention has been given to the “non-calcemic” effect of vitamin D. Several observational studies and meta-analyses demonstrated an association between circulating levels of vitamin D and outcome of many common diseases, including endocrine diseases, chronic diseases, cancer progression, and autoimmune diseases. In particular, cells of the immune system (B cells, T cells, and antigen presenting cells), due to the expression of 1α-hydroxylase (CYP27B1), are able to synthesize the active metabolite of vitamin D, which shows immunomodulatory properties. Moreover, the expression of the vitamin D receptor (VDR) in these cells suggests a local action of vitamin D in the immune response. These findings are supported by the correlation between the polymorphisms of the VDR or the CYP27B1 gene and the pathogenesis of several autoimmune diseases. Currently, the optimal plasma 25-hydroxyvitamin D concentration that is necessary to prevent or treat autoimmune diseases is still under debate. However, experimental studies in humans have suggested beneficial effects of vitamin D supplementation in reducing the severity of disease activity. In this review, we summarize the evidence regarding the role of vitamin D in the pathogenesis of autoimmune endocrine diseases, including type 1 diabetes mellitus, Addison’s disease, Hashimoto’s thyroiditis, Graves’ disease and autoimmune polyendocrine syndromes. Furthermore, we discuss the supplementation with vitamin D to prevent or treat autoimmune diseases.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Aranow C. Vitamin D, and the immune system. J Investig Med Off Publ Am Fed Clin Res. 2011;59(6):881–6. doi:10.2310/JIM.0b013e31821b8755.

    CAS  Google Scholar 

  2. Bikle DD. Vitamin D, metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319–29. doi:10.1016/j.chembiol.2013.12.016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Holick MF. Vitamin D, deficiency. New Engl J Med. 2007;357(3):266–81. doi:10.1056/NEJMra070553.

    Article  CAS  PubMed  Google Scholar 

  4. Battault S, Whiting SJ, Peltier SL, Sadrin S, Gerber G, Maixent JM. Vitamin D metabolism, functions, and needs: from science to health claims. Eur J Nutr. 2013;52(2):429–41. doi:10.1007/s00394-012-0430-5.

    Article  CAS  PubMed  Google Scholar 

  5. Muscogiuri G, Mitri J, Mathieu C, Badenhoop K, Tamer G, Orio F, et al. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol / Eur Fed Endocr Soc. 2014;171(3):R101–10. doi:10.1530/EJE-14-0158.

    Article  CAS  Google Scholar 

  6. Muscogiuri G, Altieri B, Annweiler C, Balercia G, Pal HB, Boucher BJ, et al. Vitamin D and chronic diseases: the current state of the art. Arch Toxicol. 2016. doi:10.1007/s00204-016-1804-x.

    Google Scholar 

  7. Altieri B, Grant WB, Casa SD, Orio F, Pontecorvi A, Colao A, et al. Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer. Crit Rev Food Sci Nutr. 2016. doi:10.1080/10408398.2015.1136922.

    Google Scholar 

  8. Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013;5(10):3993–4021. doi:10.3390/nu5103993.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94(1):26–34. doi:10.1210/jc.2008-1454.

    Article  CAS  PubMed  Google Scholar 

  10. Hewison M, Gacad MA, Lemire J, Adams JS. Vitamin D as a cytokine and hematopoetic factor. Rev Endocr Metab Disord. 2001;2(2):217–27.

    Article  CAS  PubMed  Google Scholar 

  11. van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97(1/2):93–101. doi:10.1016/j.jsbmb.2005.06.002.

    Article  PubMed  CAS  Google Scholar 

  12. Hossein-Nezhad A, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One. 2013;8(3):e58725. doi:10.1371/journal.pone.0058725.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin N Am. 2010;39(2):365–79. doi:10.1016/j.ecl.2010.02.010.

    Article  CAS  Google Scholar 

  14. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502–21. doi:10.3390/nu5072502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kearns MD, Alvarez JA, Seidel N, Tangpricha V. Impact of vitamin D on infectious disease. Am J Med Sci. 2015;349(3):245–62. doi:10.1097/MAJ.0000000000000360.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Eendocrinol. 2014;2(1):76–89. doi:10.1016/S2213-8587(13)70165-7.

    Article  CAS  Google Scholar 

  17. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berlin). 2010;88(5):441–50. doi:10.1007/s00109-010-0590-9.

    Article  CAS  Google Scholar 

  18. Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y. Vitamin D and autoimmunity. Scand J Rheumatol 2016:1–9 doi:10.3109/03009742.2016.1151072.

  19. Borges MC, Martini LA, Rogero MM. Current perspectives on vitamin D, immune system, and chronic diseases. Nutrition. 2011;27(4):399–404. doi:10.1016/j.nut.2010.07.022.

    Article  CAS  PubMed  Google Scholar 

  20. Grad R. Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharm Hist. 2004;46(3):106–20.

    PubMed  Google Scholar 

  21. Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun. 2000;270(3):701708. doi:10.1006/bbrc.2000.2490.

    Article  CAS  Google Scholar 

  22. Bartley J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti-Infect Ther. 2010;8(12):1359–69. doi:10.1586/eri.10.102.

    Article  CAS  PubMed  Google Scholar 

  23. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity—friends or foes? Trends Immunol. 2009;30(8):409–14. doi:10.1016/j.it.2009.05.005.

    Article  CAS  PubMed  Google Scholar 

  24. Borella E, Nesher G, Israeli E, Shoenfeld Y. Vitamin D: a new anti-infective agent? Ann NY Acad Sci. 2014;1317:76–83. doi:10.1111/nyas.12321.

    Article  CAS  PubMed  Google Scholar 

  25. Yenamandra SP, Lundin A, Arulampalam V, Yurchenko M, Pettersson S, Klein G, et al. Expression profile of nuclear receptors upon Epstein–Barr virus induced B cell transformation. Exp Oncol. 2009;31(2):92–6.

    Article  CAS  PubMed  Google Scholar 

  26. Bizzaro G, Shoenfeld Y. Vitamin D and autoimmune thyroid diseases: facts and unresolved questions. Immunol Res. 2015;61(1/2):46–52. doi:10.1007/s12026-014-8579-z.

    Article  CAS  PubMed  Google Scholar 

  27. Dimeloe S, Nanzer A, Ryanna K, Hawrylowicz C. Regulatory T cells, inflammation, and the allergic response—The role of glucocorticoids and Vitamin D. J S Biochem Mol Biol. 2010;120(2/3):86–95. doi:10.1016/j.jsbmb.2010.02.029.

    Article  CAS  Google Scholar 

  28. Figueiredo AS, Schumacher A. The T helper type 17/regulatory T cell paradigm in pregnancy. Immunology. 2016;148(1):13–21. doi:10.1111/imm.12595.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ullah MI, Koch CA, Tamanna S, Rouf S, Shamsuddin L. Vitamin D deficiency and the risk of preeclampsia and eclampsia in Bangladesh. Hormone Metab Res [Hormon- und Stoffwechselforschung] [Hormones et metabolisme]. 2013;45(9):682–7. doi:10.1055/s-0033-1345199.

    Article  CAS  Google Scholar 

  30. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179(3):1634–47.

    Article  CAS  PubMed  Google Scholar 

  31. Zhang J, Li W, Liu J, Wu W, Ouyang H, Zhang Q, et al. Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: an update by meta-analysis. Mol Cell Endocrinol. 2012;355(1):135–42. doi:10.1016/j.mce.2012.02.003.

    Article  CAS  PubMed  Google Scholar 

  32. Ban Y, Taniyama M, Yanagawa T, Yamada S, Maruyama T, Kasuga A. Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet. 2001;2:7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Kahles H, Morahan G, Todd JA, Badenhoop K. Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes. Genes Immun. 2009;10 Suppl 1:S60–3. doi:10.1038/gene.2009.93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, Ferreira GB, et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007;37(2):395–405. doi:10.1002/eji.200636043.

    Article  PubMed  CAS  Google Scholar 

  35. Moltchanova EV, Schreier N, Lammi N, Karvonen M. Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide. Diabet Med. 2009;26(7):673–8. doi:10.1111/j.1464-5491.2009.02743.x.

    Article  CAS  PubMed  Google Scholar 

  36. Stene LC, Ulriksen J, Magnus P, Joner G. Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia. 2000;43(9):1093–8.

    Article  CAS  PubMed  Google Scholar 

  37. Stene LC, Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr. 2003;78(6):1128–34.

    CAS  PubMed  Google Scholar 

  38. Marjamaki L, Niinisto S, Kenward MG, Uusitalo L, Uusitalo U, Ovaskainen ML, et al. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia. 2010;53(8):1599–607. doi:10.1007/s00125-010-1734-8.

    Article  CAS  PubMed  Google Scholar 

  39. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child. 2008;93(6):512–7. doi:10.1136/adc.2007.128579.

    Article  CAS  PubMed  Google Scholar 

  40. Wolden-Kirk H, Rondas D, Bugliani M, Korf H, Van Lommel L, Brusgaard K, et al. Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. Endocrinology. 2014;155(3):736–47. doi:10.1210/en.2013-1409.

    Article  CAS  PubMed  Google Scholar 

  41. Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol. 2011;347(1/2):106–20. doi:10.1016/j.mce.2011.08.016.

    Article  CAS  PubMed  Google Scholar 

  42. Pitocco D, Crino A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, et al. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabetes Med. 2006;23(8):920–3. doi:10.1111/j.1464-5491.2006.01921.x.

    Article  CAS  Google Scholar 

  43. Papadimitriou DT, Marakaki C, Fretzayas A, Nicolaidou P, Papadimitriou A. Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol. J Diabetes. 2013;5(3):344–8. doi:10.1111/1753-0407.12023.

    Article  CAS  PubMed  Google Scholar 

  44. Li X, Liao L, Yan X, Huang G, Lin J, Lei M, et al. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes/Met Res Rev. 2009;25(5):411–6. doi:10.1002/dmrr.977.

    Article  CAS  Google Scholar 

  45. Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care. 2010;33(7):1443–8. doi:10.2337/dc09-2297.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Michels AW, Eisenbarth GS. Autoimmune polyendocrine syndrome type 1 (APS-1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS-2). J Intern Med. 2009;265(5):530–40. doi:10.1111/j.1365-2796.2009.02091.x.

    Article  CAS  PubMed  Google Scholar 

  47. Bratland E, Husebye ES. Cellular immunity and immunopathology in autoimmune Addison’s disease. Mol Cell Endocrinol. 2011;336(1/2):180–90. doi:10.1016/j.mce.2010.12.015.

    Article  CAS  PubMed  Google Scholar 

  48. Pani MA, Seissler J, Usadel KH, Badenhoop K. Vitamin D receptor genotype is associated with Addison’s disease. Eur J Endocrinol / Eur Fed Endocr Soc. 2002;147(5):635–40.

    Article  CAS  Google Scholar 

  49. Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, Seissler J, et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison’s disease, Hashimoto’s thyroiditis, Graves’ disease, and type 1 diabetes mellitus in Germans. Eur J Endocrinol / Eur Fed Endocr Soc. 2004;151(2):193–7.

    Article  CAS  Google Scholar 

  50. Fichna M, Zurawek M, Januszkiewicz-Lewandowska D, Gryczynska M, Fichna P, Sowinski J. Association of the CYP27B1 C(-1260)A polymorphism with autoimmune Addison’s disease. Exp Clin Endocrinol Diabetes Off J German Soc Endocrinol German Diabetes Assoc. 2010;118(8):544–9. doi:10.1055/s-0029-1241206.

    Article  CAS  Google Scholar 

  51. Jennings CE, Owen CJ, Wilson V, Pearce SH. A haplotype of the CYP27B1 promoter is associated with autoimmune Addison’s disease but not with Graves’ disease in a UK population. J Mol Endocrinol. 2005;34(3):859–63. doi:10.1677/jme.1.01760.

    Article  CAS  PubMed  Google Scholar 

  52. Gittoes NJ. Vitamin D—what is normal according to latest research and how should we deal with it? Clin Med. 2016;16(2):171–4. doi:10.7861/clinmedicine.16-2-171.

    Article  Google Scholar 

  53. Ramagopalan SV, Goldacre R, Disanto G, Giovannoni G, Goldacre MJ. Hospital admissions for vitamin D-related conditions and subsequent immune-mediated disease: record-linkage studies. BMC Med. 2013;11:171. doi:10.1186/1741-7015-11-171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Bellastella G, Maiorino MI, Petrizzo M, De Bellis A, Capuano A, Esposito K, et al. Vitamin D and autoimmunity: what happens in autoimmune polyendocrine syndromes? J Endocrinol Investig. 2015;38(6):629–33. doi:10.1007/s40618-014-0233-z.

    Article  CAS  Google Scholar 

  55. Montoli A, Colussi G, Minetti L. Hypercalcaemia in Addison’s disease: calciotropic hormone profile and bone histology. J Intern Med. 1992;232(6):535–40.

    Article  CAS  PubMed  Google Scholar 

  56. Suliman AM, Freaney R, Smith TP, McBrinn Y, Murray B, McKenna TJ. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency. Clin Endocrinol. 2003;59(3):380–7.

    Article  CAS  Google Scholar 

  57. Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr. 2015;69(3):291–6. doi:10.1038/ejcn.2014.265.

    Article  CAS  PubMed  Google Scholar 

  58. Wang J, Lv S, Chen G, Gao C, He J, Zhong H, et al. Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients. 2015;7(4):2485–98. doi:10.3390/nu7042485.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Sonmezgoz E, Ozer S, Yilmaz R, Onder Y, Butun I, Bilge S. Hypovitaminosis D in children with Hashimotos thyroiditis. Rev Med Chil. 2016;144(5):611–6. doi:10.4067/S0034-98872016000500009.

    Article  PubMed  Google Scholar 

  60. Muscogiuri G, Mari D, Prolo S, Fatti LM, Cantone MC, Garagnani P, et al. Hydroxyvitamin D deficiency and its relationship to autoimmune thyroid disease in the elderly. Int J Environ Res Public Health. 2016;13(9). doi:10.3390/ijerph13090850.

  61. Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, Evangelopoulos AD, Kotsiris DA, Tzortzinis AA. Is vitamin D related to pathogenesis and treatment of Hashimoto’s thyroiditis? Hell J Nucl Med. 2015;18(3):222–7.

    PubMed  Google Scholar 

  62. Maciejewski A, Wojcicka M, Roszak M, Losy J, Lacka K. Assessment of vitamin D level in autoimmune thyroiditis patients and a control group in the Polish population. Adv Clin Exp Med Off Organ Wroclaw Med Univ. 2015;24(5):801–6. doi:10.17219/acem/29183.

    Article  Google Scholar 

  63. Chaudhary S, Dutta D, Kumar M, Saha S, Mondal SA, Kumar A, et al. Vitamin D supplementation reduces thyroid peroxidase antibody levels in patients with autoimmune thyroid disease: an open-labeled randomized controlled trial. Indian J Endocrinol Metab. 2016;20(3):391–8. doi:10.4103/2230-8210.179997.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Effraimidis G, Badenhoop K, Tijssen JG, Wiersinga WM. Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol / Eur Fed Endocr Soc. 2012;167(1):43–8. doi:10.1530/EJE-12-0048.

    Article  CAS  Google Scholar 

  65. Goswami R, Marwaha RK, Gupta N, Tandon N, Sreenivas V, Tomar N, et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr. 2009;102(3):382–6. doi:10.1017/S0007114509220824.

    Article  CAS  PubMed  Google Scholar 

  66. Yasmeh J, Farpour F, Rizzo V, Kheradnam S, Sachmechi I. Hashimoto thyroiditis not associated with vitamin D deficiency. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2016;22(7):809–13. doi:10.4158/EP15934.OR.

    Google Scholar 

  67. Yazici D, Yavuz D, Tarcin O, Sancak S, Deyneli O, Akalin S. Vitamin D receptor gene ApaI, TaqI, FokI, and BsmI polymorphisms in a group of Turkish patients with Hashimoto’s thyroiditis. Minerva Endocrinol. 2013;38(2):195–201.

    CAS  PubMed  Google Scholar 

  68. Inoue N, Watanabe M, Ishido N, Katsumata Y, Kagawa T, Hidaka Y, et al. The functional polymorphisms of VDR, GC, and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. Clin Exp Immunol. 2014;178(2):262–9. doi:10.1111/cei.12420.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Feng M, Li H, Chen SF, Li WF, Zhang FB. Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine. 2013;43(2):318–26. doi:10.1007/s12020-012-9812-y.

    Article  CAS  PubMed  Google Scholar 

  70. Giovinazzo S, Vicchio TM, Certo R, Alibrandi A, Palmieri O, Campenni A, et al. Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto’s thyroiditis. Endocrine. 2016. doi:10.1007/s12020-016-0942-5.

    Google Scholar 

  71. Agmon-Levin N, Theodor E, Segal RM, Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol. 2013;45(2):256–66. doi:10.1007/s12016-012-8342-y.

    Article  CAS  PubMed  Google Scholar 

  72. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2(3):119–25.

    Article  PubMed  Google Scholar 

  73. Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, et al. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease. Endocrine. 2012;42(3):739–41. doi:10.1007/s12020-012-9679-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Menconi F, Marcocci C, Marino M. Diagnosis and classification of Graves’ disease. Autoimmun Rev. 2014;13(4/5):398–402. doi:10.1016/j.autrev.2014.01.013.

    Article  PubMed  Google Scholar 

  75. Marino M, Latrofa F, Menconi F, Chiovato L, Vitti P. Role of genetic and non-genetic factors in the etiology of Graves’ disease. J Endocrinol Investig. 2015;38(3):283–94. doi:10.1007/s40618-014-0214-2.

    Article  CAS  Google Scholar 

  76. Jurecka-Lubieniecka B, Bednarczuk T, Ploski R, Krajewska J, Kula D, Kowalska M, et al. Differences in gene–gene interactions in Graves’ disease patients stratified by age of onset. PLoS One. 2016;11(3):e0150307. doi:10.1371/journal.pone.0150307.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Wiersinga WM. Thyroid autoimmunity. Endocr Dev. 2014;26:139–57. doi:10.1159/000363161.

    Article  CAS  PubMed  Google Scholar 

  78. Wiersinga WM. Clinical relevance of environmental factors in the pathogenesis of autoimmune thyroid disease. Endocrinol Metab. 2016;31(2):213–22. doi:10.3803/EnM.2016.31.2.213.

    Article  Google Scholar 

  79. Xu MY, Cao B, Yin J, Wang DF, Chen KL, Lu QB. Vitamin D and Graves’ disease: a meta-analysis update. Nutrients. 2015;7(5):3813–27. doi:10.3390/nu7053813.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Rotondi M, Chiovato L. Vitamin D deficiency in patients with Graves’ disease: probably something more than a casual association. Endocrine. 2013;43(1):3–5. doi:10.1007/s12020-012-9776-y.

    Article  CAS  PubMed  Google Scholar 

  81. Choi YM, Kim WG, Kim TY, Bae SJ, Kim HK, Jang EK, et al. Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in premenopausal women. Thyroid Off J Am Thyroid Assoc. 2014;24(4):655–61. doi:10.1089/thy.2013.0460.

    Article  CAS  Google Scholar 

  82. Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best Pract Res Clin Endocrinol Metab. 2011;25(4):617–32. doi:10.1016/j.beem.2011.04.009.

    Article  PubMed  CAS  Google Scholar 

  83. Zhou H, Xu C, Gu M. Vitamin D receptor (VDR) gene polymorphisms and Graves’ disease: a meta-analysis. Clin Endocrinol. 2009;70(6):938–45. doi:10.1111/j.1365-2265.2008.03413.x.

    Article  CAS  Google Scholar 

  84. Cutolo M. Autoimmune polyendocrine syndromes. Autoimmun Rev. 2014;13(2):85–9. doi:10.1016/j.autrev.2013.07.006.

    Article  CAS  PubMed  Google Scholar 

  85. Lindmark E, Chen Y, Georgoudaki AM, Dudziak D, Lindh E, Adams WC, et al. AIRE expressing marginal zone dendritic cells balances adaptive immunity and T-follicular helper cell recruitment. J Autoimmun. 2013;42:62–70. doi:10.1016/j.jaut.2012.11.004.

    Article  CAS  PubMed  Google Scholar 

  86. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–538. doi:10.1210/jc.2010-2704.

    Article  CAS  PubMed  Google Scholar 

  87. Aspray TJ, Bowring C, Fraser W, Gittoes N, Javaid MK, Macdonald H, et al. National Osteoporosis Society vitamin D guideline summary. Age Aging. 2014;43(5):592–5. doi:10.1093/ageing/afu093.

    Article  Google Scholar 

  88. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30. doi:10.1210/jc.2011-0385.

    Article  CAS  PubMed  Google Scholar 

  89. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol. 2012;76(3):315–25. doi:10.1111/j.1365-2265.2011.04261.x.

    Article  CAS  Google Scholar 

  90. Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology. 1995;136(3):866–72. doi:10.1210/endo.136.3.7867594.

    Article  CAS  PubMed  Google Scholar 

  91. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12(2):127–36. doi:10.1016/j.autrev.2012.07.007.

    Article  CAS  PubMed  Google Scholar 

  92. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204–10.

    CAS  PubMed  Google Scholar 

  93. Heaney RP. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005;97(1-2):13–9. doi:10.1016/j.jsbmb.2005.06.020.

    Article  CAS  PubMed  Google Scholar 

  94. Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol. 2004;89/90(1/5):575–9. doi:10.1016/j.jsbmb.2004.03.038.

    Article  CAS  Google Scholar 

  95. Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease? A systematic review. Semin Arthritis Rheum. 2011;40(6):512–531 e8. doi:10.1016/j.semarthrit.2010.07.009.

    Article  CAS  PubMed  Google Scholar 

  96. Gloth III FM, Tobin JD, Sherman SS, Hollis BW. Is the recommended daily allowance for vitamin D too low for the homebound elderly? J Am Geriatr Soc. 1991;39(2):137–41.

    Article  PubMed  Google Scholar 

  97. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003;18(2):343–51. doi:10.1359/jbmr.2003.18.2.343.

    Article  CAS  PubMed  Google Scholar 

  98. Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr. 2001;55(12):1091–7. doi:10.1038/sj.ejcn.1601275.

    Article  CAS  PubMed  Google Scholar 

  99. Munro I. Derivation of tolerable upper intake levels of nutrients. Am J Clin Nutr. 2001;74(6):865–7.

    CAS  PubMed  Google Scholar 

  100. Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr. 2006;136(4):1117–22.

    CAS  PubMed  Google Scholar 

  101. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(2):582S–6S.

    CAS  PubMed  Google Scholar 

  102. Zittermann A, Prokop S, Gummert JF, Borgermann J. Safety issues of vitamin D supplementation. Anticancer Agents Med Chem. 2013;13(1):4–10.

    Article  CAS  PubMed  Google Scholar 

  103. Lowe H, Cusano NE, Binkley N, Blaner WS, Bilezikian JP. Vitamin D toxicity due to a commonly available “over the counter” remedy from the Dominican Republic. J Clin Endocrinol Metab. 2011;96(2):291–5. doi:10.1210/jc.2010-1999.

    Article  CAS  PubMed  Google Scholar 

  104. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D’Erasmo E, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93(8):3015–20. doi:10.1210/jc.2008-0350.

    Article  CAS  PubMed  Google Scholar 

  105. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab. 2011;96(3):E447–52. doi:10.1210/jc.2010-2230.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors contribution

B.A. and G.M. designed the study. B.A., G.M., L.B., C.M., C.V.V., L.M. and G.B. participated in the literature search and performed the selection of studies. B.A. wrote the Introduction, Methods and the Conclusion of the review, as well as the paragraphs on Addison’s disease and on vitamin D supplementation. C.V.V. supported B.A. in writing the Introduction and the paragraphs on vitamin D supplementation. G.M., S.S., N.B. and C.L.R. collaborated to the preparation of the manuscript providing relevant suggestions and corrections according to their long-lasting expertise in different research fields. L.B. wrote the paragraph on Grave’s disease and autoimmune polyendocrine syndromes. C.M. wrote the paragraph on diabetes mellitus. L.M. prepared the figure and wrote the paragraph on clinical and basic evidence. G.B. wrote the paragraph on Hashimoto thyroiditis. V.M.A., G.T. and G.B. contributed to the final version of the manuscript. A.C., A.P. and S.D.C. coordinated and supervised the preparation of the manuscript. All the authors reviewed and approved the final version of the manuscript.

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolic Diseases, Institute of Medical Pathology, Catholic University of the Sacred Heart, Rome, Italy

    Barbara Altieri, Alfredo Pontecorvi & Silvia Della Casa

  2. Ios and Coleman Medicina Futura Medical Center, University Federico II, Naples, Italy

    Giovanna Muscogiuri & Luigi Barrea

  3. Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium

    Chantal Mathieu

  4. Emergency Department, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy

    Carla V. Vallone

  5. Comando Brigata Alpina Julia/Multinational Land Force, Medical Service, Udine, Italy

    Luca Mascitelli

  6. TSEM med Swiss SA, Lugano, Switzerland

    Giorgia Bizzaro

  7. Department of Urology, Bolognini Hospital, Seriate, Italy

    Vincenzo M. Altieri

  8. Division of Endocrinology, Department of Clinical and Molecular Sciences, Umberto I Hospital, Polytechnic University of Marche, Ancona, Italy

    Giacomo Tirabassi & Giancarlo Balercia

  9. Department of Clinical Medicine and Surgery, University “Federico II”, Naples, Italy

    Silvia Savastano & Annamaria Colao

  10. Laboratory of Clinical Pathology, San Antonio Hospital, Tolmezzo, Italy

    Nicola Bizzaro

  11. Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital of Wuerzburg, Wuerzburg, Germany

    Cristina L. Ronchi

Authors
  1. Barbara Altieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanna Muscogiuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luigi Barrea
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chantal Mathieu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carla V. Vallone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luca Mascitelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giorgia Bizzaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vincenzo M. Altieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Giacomo Tirabassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Giancarlo Balercia
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Silvia Savastano
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Nicola Bizzaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Cristina L. Ronchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Annamaria Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Alfredo Pontecorvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Silvia Della Casa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara Altieri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Altieri, B., Muscogiuri, G., Barrea, L. et al. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord 18, 335–346 (2017). https://doi.org/10.1007/s11154-016-9405-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-016-9405-9

Keywords

  • Vitamin D
  • Autoimmunity
  • Type 1 diabetes mellitus
  • Addison’s disease
  • Hashimoto’s thyroiditis
  • Graves’ disease
  • Autoimmune polyendocrine syndromes
  • Environment
  • Lifestyle